(Reuters) - Brazil's move will discourage investment in the country, sending a "chilling signal to research-based companies about the attractiveness of undertaking risky research on diseases that affect the developing world," Merck said in a statement
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment